Axsome Therapeutics (AXSM) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Axsome Therapeutics, as the data feed reports them.

Analysts' mean target, 21 analysts
$264.62
95.2% above the price

The 21 analysts reported by the data feed have a mean price target for Axsome Therapeutics of $264.62, 95.2% above the $135.59 price (range $220.00–$315.00). 9.60% of the float was sold short as of Oct 30, 2026. Institutions hold 77.7% of the shares and insiders 15.0%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$264.62+95.2% vs price
Analysts
21
Short interest
9.60%of float, Oct 30, 2026
Short ratio
3.34 days
Institutions
77.7%
Insiders
15.02%
Beta
0.83

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

21 analysts covering Axsome Therapeutics, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $135.59.

Analysts' price targets for Axsome Therapeutics
Mean price target$264.6295.2% above the price (+95.2%)
Median price target$268.0097.7% above the price (+97.7%)
Highest target$315.00132.3% above the price (+132.3%)
Lowest target$220.0062.3% above the price (+62.3%)
Analysts with a target21

Ratings this month · 22 analysts

Strong buy 3(14%)Buy 18(82%)Hold 1(5%)
Analysts' ratings of Axsome Therapeutics this month, by rating
RatingAnalystsShare
Strong buy314%
Buy1882%
Hold15%
Sell00%
Strong sell00%

The feed averages these to 1.23 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Axsome Therapeutics

Ownership of Axsome Therapeutics
Held by institutions77.7%622 institutions; percent of shares outstanding
Held by institutions, of the float91.4%
Held by insiders15.02%percent of shares outstanding
Shares outstanding52.6M
Float44.68Mshares available to trade
Insiders' net purchases, six months−13.64K9 purchases (197.72K shares), 9 sales (211.35K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Axsome Therapeutics
Shares short3.26Mas of Oct 30, 2026
Percent of float9.60%shares short ÷ float
Percent of shares outstanding6.20%shares short ÷ shares outstanding
Short ratio (days to cover)3.34shares short ÷ average daily volume

Axsome Therapeutics short interest from FINRA, with its history

Trading figures

Trading figures for Axsome Therapeutics
Beta0.83movement against the market; 1 moves with it
52-week high$260.19
52-week low$123.00
Average volume, 3 months860.96Kshares a day
Average volume, 10 days1.1Mshares a day

Questions and answers

What is the analysts' price target for Axsome Therapeutics (AXSM)?

As reported by the data feed, the mean price target of the 21 analysts covering Axsome Therapeutics is $264.62, 95.2% above the latest price of $135.59. The highest target is $315.00 and the lowest $220.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Axsome Therapeutics stock?

Of the 22 ratings the data feed reports for the current month, 3 are strong buy, 18 buy, 1 hold, 0 sell and 0 strong sell.

How many Axsome Therapeutics shares are sold short?

As reported by the data feed, 3.26M shares were sold short, 9.60% of the float as of Oct 30, 2026. At the average daily volume that is 3.34 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Axsome Therapeutics stock?

As reported by the data feed, institutions hold 77.7% of the shares (622 institutions) and insiders 15.0%. There are 52.6M shares outstanding, of which 44.68M are in the float.

How much does Axsome Therapeutics stock move with the market?

Its beta, as reported by the data feed, is 0.83: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $123.00 and $260.19.

Cite this page

Funkfolio, “Axsome Therapeutics (AXSM) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/AXSM/statistics

Underlying data: Yahoo Finance.